Ispecimen Share Price (NASDAQ: ISPC)

$0.71

▲

-0.03

(-4.05%)

Live

Last updated on August 28, 2025 at 11:31 pm IST

$₹

Check the interactive Ispecimen Stock chart to analyse performance

Ispecimen stock performance

as on August 28, 2025 at 11:31 pm IST

Today's Low:$0.70
Today's High:$0.72
$0.71
1.41%
Downside
Day's Volatility :2.78%
Upside
1.39%
52 Weeks Low:$0.70
52 Weeks High:$8.30
$0.71
1.92%
Downside
52 Weeks Volatility :91.61%
Upside
91.45%

Ispecimen Stock Returns

Period	Ispecimen Inc	Index (Russel 2000)
3 Months	-38.32%	0.0%
6 Months	-54.02%	0.0%
1 Year	-87.15%	0.0%
3 Years	-98.32%	-6.9%

Ispecimen Inc Key Stats

Check Ispecimen key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.74
Open	$0.79
Today's High	$0.7221
Today's Low	$0.69
Market Capitalization	$4.4M
Today's Volume	$638.5K
52 Week High	$8.3
52 Week Low	$0.696399
Revenue TTM	$5.9M
EBITDA	$-10.7M
Earnings Per Share (EPS)	$-8.91
Profit Margin	-172.51%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-303.74%

Stock Returns calculator for Ispecimen Stock including INR - Dollar returns

The Ispecimen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ispecimen investment value today

Current value as on today

₹16,686

Returns

₹83,314

(-83.31%)

Returns from Ispecimen Stock

₹87,674 (-87.67%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Ispecimen Stock

288%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Ispecimen Stock from India on INDmoney has increased by 288% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Ispecimen Inc

Name
Holdings %
Name
Holdings %
UBS Group AG
0.55%
Geode Capital Management, LLC
0.27%
XTX Topco Ltd
0.25%
Tower Research Capital LLC
0.16%
BlackRock Inc
0.07%

Analyst Recommendation on Ispecimen Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Ispecimen(by analysts ranked 0 to 5 stars)

Ispecimen Share Price Target

What analysts predicted

Upside of 322.54%

Target:

$3.00

Current:

$0.71

Ispecimen share price target is $3.00, a slight Upside of 322.54% compared to current price of $0.71 as per analysts' prediction.

Ispecimen Stock Insights

Price Movement
In the last 7 days, ISPC stock has moved down by -8.7%
Decreasing Revenue
Revenue is down for the last 5 quarters, 2.86M → 713.13K (in $), with an average decrease of 28.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -6.04M → -1.04M (in $), with an average increase of 161.5% per quarter
ISPC vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 33.1% return, outperforming this stock by 120.2%
ISPC vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 83.2% return, outperforming this stock by 181.5%
Price to Sales
ForISPC every $1 of sales, investors are willing to pay $0.2, whereas for Idexx Laboratories, Inc., the investors are paying $12.9 for every $1 of sales.

Ispecimen Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$4.3M	↓ 2.2%
Net Income	$-4.7M	↓ 11.6%
Net Profit Margin	-109.97%	↑ 11.7%

	FY20	Y/Y Change
Revenue	$8.2M	↑ 90.4%
Net Income	$-6.8M	↑ 42.98%
Net Profit Margin	-82.58%	↑ 27.39%

	FY21	Y/Y Change
Revenue	$11.1M	↑ 36.06%
Net Income	$-10.0M	↑ 48.2%
Net Profit Margin	-89.95%	↓ 7.37%

	FY22	Y/Y Change
Revenue	$10.4M	↓ 6.58%
Net Income	$-9.0M	↓ 9.74%
Net Profit Margin	-86.91%	↑ 3.04%

	FY23	Y/Y Change
Revenue	$9.9M	↓ 4.56%
Net Income	$-11.1M	↑ 22.77%
Net Profit Margin	-111.8%	↓ 24.89%

	FY24	Y/Y Change
Revenue	$9.3M	↓ 6.42%
Net Income	$-12.5M	↑ 12.6%
Net Profit Margin	-134.51%	↓ 22.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$2.3M	↓ 11.07%
Net Income	$-2.9M	↓ 5.56%
Net Profit Margin	-126.73%	↓ 7.4%

	Q2 FY24	Q/Q Change
Revenue	$2.9M	↑ 25.05%
Net Income	$-2.1M	↓ 27.33%
Net Profit Margin	-73.65%	↑ 53.08%

	Q3 FY24	Q/Q Change
Revenue	$2.7M	↓ 7.04%
Net Income	$-1.4M	↓ 31.73%
Net Profit Margin	-54.09%	↑ 19.56%

	Q4 FY24	Q/Q Change
Revenue	$1.5M	↓ 44.57%
Net Income	$-6.0M	↑ 319.96%
Net Profit Margin	-409.81%	↓ 355.72%

	Q1 FY25	Q/Q Change
Revenue	$1.1M	↓ 28.33%
Net Income	$-1.7M	↓ 72.57%
Net Profit Margin	-156.82%	↑ 252.99%

	Q2 FY25	Q/Q Change
Revenue	$713.1K	↓ 32.56%
Net Income	$-1.0M	↓ 36.85%
Net Profit Margin	-146.85%	↑ 9.97%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$2.2M	↑ 6.8%

	FY20	Y/Y Change
Profit	$4.6M	↑ 111.87%

	FY21	Y/Y Change
Profit	$5.9M	↑ 28.0%

	FY22	Y/Y Change
Profit	$5.6M	↓ 4.09%

	FY23	Y/Y Change
Profit	$5.1M	↓ 9.52%

	FY24	Y/Y Change
Profit	$4.0M	↓ 21.92%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$693.3K	↑ 13.55%

	Q2 FY24	Q/Q Change
Profit	$832.5K	↑ 20.08%

	Q3 FY24	Q/Q Change
Profit	$1.1M	↑ 33.06%

	Q4 FY24	Q/Q Change
Profit	$151.4K	↓ 86.34%

	Q1 FY25	Q/Q Change
Profit	$400.2K	↑ 164.44%

	Q2 FY25	Q/Q Change
Profit	$269.0K	↓ 32.8%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-2.7M	↓ 0.07%
Investing Cash Flow	$-1.5M	↑ 43.84%
Financing Cash Flow	$3.1M	↓ 12.42%

	FY20	Y/Y Change
Operating Cash Flow	$-288.4K	↓ 89.24%
Investing Cash Flow	$-1.1M	↓ 25.26%
Financing Cash Flow	$2.0M	↓ 33.96%

	FY21	Y/Y Change
Operating Cash Flow	$-10.7M	↑ 3599.43%
Investing Cash Flow	$-1.0M	↓ 5.87%
Financing Cash Flow	$38.7M	↑ 1806.01%

	FY22	Y/Y Change
Operating Cash Flow	$-5.8M	↓ 45.47%
Investing Cash Flow	$-3.2M	↑ 207.46%
Financing Cash Flow	$-3.4M	↓ 108.83%

	FY23	Y/Y Change
Operating Cash Flow	$-5.8M	↓ 0.17%
Investing Cash Flow	$-7.2M	↑ 126.51%
Financing Cash Flow	$70.9K	↓ 102.07%

	FY24	Y/Y Change
Operating Cash Flow	$-8.3M	↑ 42.29%
Investing Cash Flow	$2.0M	↓ 127.39%
Financing Cash Flow	$5.8M	↑ 8108.47%

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 700.44%
Investing Cash Flow	$1.9M	↓ 367.96%
Financing Cash Flow	$-118.9K	↓ 88.81%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-1.5M	↓ 25.72%
Investing Cash Flow	$295.1K	↓ 84.77%
Financing Cash Flow	$1.3M	↓ 1198.36%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 29.87%
Investing Cash Flow	$-180.0K	↓ 160.98%
Financing Cash Flow	$860.0K	↓ 34.13%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 69.33%
Investing Cash Flow	$-73.1K	-
Financing Cash Flow	$3.8M	↑ 0.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-192.2K	↓ 82.46%
Investing Cash Flow	$-454.0	↓ 99.38%
Financing Cash Flow	$-1.1K	↓ 100.03%

Ispecimen Technicals Summary

Sell

Neutral

Buy

Ispecimen is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ispecimen Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ispecimen Inc	-30.17%	-54.02%	-87.15%	-98.32%	-99.48%
Agilent Technologies Inc.	-0.96%	-6.6%	-15.86%	-7.35%	18.19%
Idexx Laboratories, Inc.	11.83%	45.31%	33.1%	83.6%	63.88%
Thermo Fisher Scientific, Inc.	1.24%	-6.71%	-20.39%	-12.32%	13.79%
Danaher Corp.	-0.89%	-0.35%	-22.95%	-25.91%	-0.71%
Iqvia Holdings Inc.	-2.96%	1.23%	-23.73%	-13.48%	15.3%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ispecimen Inc	NA	NA	NA	0.0	-3.04	-0.77	NA	0.21
Agilent Technologies Inc.	29.23	29.23	1.74	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	53.52	53.52	4.8	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.28	28.28	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.88	43.88	2.07	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.4	27.4	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ispecimen Inc	Buy	$4.4M	-99.48%	NA	-172.51%
Agilent Technologies Inc.	Buy	$33.7B	18.19%	29.23	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	63.88%	53.52	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.5B	13.79%	28.28	15.24%
Danaher Corp.	Buy	$147.7B	-0.71%	43.88	14.21%
Iqvia Holdings Inc.	Buy	$32.1B	15.3%	27.4	7.88%

About Ispecimen Inc

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

Organization	Ispecimen
Employees	24
CEO	Mr. Robert Bradley Lim
Industry	Miscellaneous

Key Management of Ispecimen Inc

Name	Title
Mr. Robert Bradley Lim	CEO, Treasurer, Secretary & Director
Ms. Katharyn Field	President
Mr. Yuying Liang	Chief Financial Officer

Important FAQs about investing in ISPC Stock from India :

What is Ispecimen share price today?

Ispecimen share price today is $0.71 as on August 28, 2025 at 11:31 pm IST. Ispecimen share today touched a day high of $0.72 and a low of $0.70.

What is the 52 week high and 52 week low for Ispecimen share?

Ispecimen share touched a 52 week high of $8.30 and a 52 week low of $0.70. Ispecimen stock price today i.e. August 28, 2025 at 11:31 pm IST is trending at $0.71, lower by 91.45% versus the 52 week high.

How to invest in Ispecimen Stock (ISPC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ispecimen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ispecimen Shares that will get you 2.1127 shares as per Ispecimen share price of $0.71 per share as on August 28, 2025 at 11:31 pm IST.

What is the minimum amount required to buy Ispecimen Stock (ISPC) from India?

Indian investors can start investing in Ispecimen (ISPC) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Ispecimen stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Ispecimen share’s latest price of $0.71 as on August 28, 2025 at 11:31 pm IST, you will get 14.0845 shares of Ispecimen. Learn more about fractional shares .

What are the returns that Ispecimen has given to Indian investors in the last 5 years?

Ispecimen stock has given -99.48% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?